| Current Price | $0.21 | Mkt Cap | $130.2M |
|---|---|---|---|
| Open | $0.21 | P/E Ratio | 0.00 |
| Prev. Close | $0.21 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.20 - $0.21 | Volume | 224,562 |
| 52-Wk Range | $0.19 - $0.22 | Avg. Daily Vol. | 1,103,976 |
| Current Price | $0.21 | Mkt Cap | $130.2M |
|---|---|---|---|
| Open | $0.21 | P/E Ratio | 0.00 |
| Prev. Close | $0.21 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.20 - $0.21 | Volume | 224,562 |
| 52-Wk Range | $0.19 - $0.22 | Avg. Daily Vol. | 1,103,976 |
The best Bull and Bear pitches based on recency and number of recommendations.
Recently approved drug DCVax-L apporved in Germany ahead of phase III trail completion. WIll be allowed to prescribed for 5yr and can be extended. Previous trials point to sustain life span of existing brain cancer tumor patients. See huge upside
Every once in a while I check in to see what Northwest is up to. Recently there was a price spike but I didn't have time to look into it. It turns out there was nothing to justify it. Northwest Bio doesn't have the guts to issue an earnings PR,… More
Read the most recent pitches from players about NWBO.
Recs
zzlangerhans
(99.61)
Submitted: 10/21/2016 11:16:46 PM :
Start Price:
$0.56
NASDAQ OTHER:NWBO Score:
+118.46
Every once in a while I check in to see what Northwest is up to. Recently there was a price spike but I didn't have time to look into it. It turns out there was nothing to justify it. Northwest Bio doesn't have the guts to issue an earnings PR, likely because they would have to admit they are making no clinical progress but continuing to feed cash from dilutive financings into Linda Powers' slush fund Cognate. They filed a 10Q as required but it contains nothing material regarding their progress or lack thereof in clinical trials. The one positive is that it does appear that the stock is in a death spiral with successive financings at lower and lower share price that are unable to keep up with the quarterly burn. The next 10Q should be interesting. Of course, given Northwest's history, there's no limit to the reverse splitting, nonsense PR spouting we might expect once Powers is backed into a corner.
Recs
NHWeston102
(76.63)
Submitted: 5/23/2016 2:43:02 PM :
Start Price:
$0.77
NASDAQ OTHER:NWBO Score:
+134.48
Collapsing.
Recs
goodguygonebad
(< 20)
Submitted: 2/24/2015 7:05:46 PM :
Start Price:
$6.80
NASDAQ OTHER:NWBO Score:
-153.82
NWBO will present data from DCVAX-direct phase I trial as well as DCVAX-L phase I and II trials. Presentation will demonstrate SIGNIFICANT efficacy for both drugs, pushing stock higher. I estimate $10 - $12 per share.
Find the members with the highest scoring picks in NWBO.
whatsthepoint (99.98) Score: +306.60
The Score Leader is the player with the highest score across all their picks in NWBO.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| walt373 | 99.92 | 8/19/2011 |
|
5Y | $8.00 | -97.40% | +193.95% | +291.35 | 0 Comment | |
| walt393 | 99.94 | 8/18/2011 |
|
5Y | $7.68 | -97.29% | +185.02% | +282.31 | 0 Comment | |
| Europecv | 30.03 | 10/18/2011 |
|
5Y | $9.28 | -97.76% | +176.39% | +274.14 | 0 Comment | |
|
cjlee001 | 89.04 | 10/27/2011 |
|
5Y | $8.89 | -97.66% | +160.17% | +257.83 | 0 Comment |
| HedgeFund007 | 98.30 | 10/28/2011 |
|
1Y | $8.32 | -97.50% | +159.41% | +256.91 | 0 Comment | |
| wagnerf60 | 23.05 | 6/2/2011 |
|
5Y | $14.00 | -98.51% | +153.13% | +251.64 | 0 Comment | |
| williamstep | 98.96 | 5/23/2011 |
|
5Y | $10.58 | -98.03% | +151.74% | +249.78 | 0 Comment | |
| vettelvettel | 99.39 | 5/23/2011 |
|
5Y | $10.72 | -98.06% | +151.71% | +249.77 | 0 Comment | |
| HikerAnthony | 95.73 | 5/26/2011 |
|
5Y | $11.36 | -98.17% | +151.50% | +249.66 | 0 Comment | |
| thefooloffoools | 98.94 | 5/23/2011 |
|
5Y | $9.15 | -97.73% | +151.59% | +249.32 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
